Damascus-Sana
The Central Company for Pharmaceutical Industries “Main Pharma” today opened a factory for the manufacture of chemical drugs against cancerous tumors in the industrial city of Adra in Damascus countryside.
Adnan Jaafo, CEO of the company, explained in a statement to SANA that the factory opened with national expertise “is the first of its kind in Syria and the Arab region in terms of advanced production lines and modern technologies”.
The plant covers 70 percent of the total chemotherapeutic drugs and its production, he said.
In 2020, the plant will start producing 8 varieties of aseptic liquid line and 8 varieties of compressed grain line as the first stage to reach the target of 20 varieties in each line by the end of next year, according to the CEO, who confirmed that these varieties will achieve the quality equation with more price.
It is noteworthy that Syria imports all drugs oncology from abroad with other quality drugs and vaccines, while the national production covers about 90 percent of the rest of the varieties of the local market need.
Ines Svan